# Cancer systems immunology reveals myeloidâ€”T cell interactions and B cell activation mediate response to checkpoint inhibition in metastatic breast cancer

[Preprint](https://doi.org/10.1101/2025.06.09.658361)

Authors: Edgar Gonzalez1*, Jesse Kreger2*, Yingtong Liu2, Xiaojun Wu2, Arianna Barbetta3, Aaron G. Baugh1, Batul Al-Zubeidy1, Julie Jang1, Sarah M. Shin4, Zhehao Zhang4, Matthew Jacobo1, Vered Stearns5, Roisin M. Connolly6, Won Jin Ho4, Juliet Emamaullee3, Adam L. MacLean2**, Evanthia T. Roussos Torres1**

*Equal contributions, Co-first authors
**Equal contributions, Co-senior, Co-corresponding

Affiliations:
1.	University of Southern California, Department of Medicine, Division of Oncology, Keck School of Medicine, Los Angeles, CA
2.	Department of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA, USA
3.	University of Southern California, Department of Surgery, Keck School of Medicine, Los	 Angeles, CA
4.	Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
5.	Weill Cornell Medical Center, Cornell University, New York, NY
6.	University College Cork, Cork, Ireland

### Project contents
 - `Supplementary File 1` : description
 - `Supplementary File 2` : description
 - `Supplementary File 3` : full searchable cellchat results for 4 treatment conditions (V, E, EPC, and PC) for CC-suppression and CC-model 

### Contributors
<a href="https://github.com/maclean-lab/FMCs_for_HSCs/graphs/contributors">
  <img src="https://contributors-img.web.app/image?repo=maclean-lab/FMCs_for_HSCs" />
</a>
